Key result
The acute-to-chronic glycemic ratio (ABG/eAG) was associated with adverse in-hospital outcomes in diabetic patients with STEMI undergoing PCI (OR 2.45; 95% CI 1.24-4.82; P=0.010).
Why the study?
It was unknown whether the acute-to-chronic glycemic ratio provides better prognostic value than admission glycemia alone in patients with STEMI undergoing PCI.
Does the acute-to-chronic glycemic ratio (ABG/eAG) improve prognostic prediction compared to admission blood glucose alone for in-hospital outcomes in patients with STEMI undergoing PCI?
Population
1300 consecutive patients with STEMI treated with PCI
Comparison
Acute-to-chronic glycemic ratio (ABG/eAG) vs admission blood glucose (ABG) alone
Design
Observational cohort study
Follow-up
In-hospital
Authors
Loading...
May enhance in-hospital risk stratification in diabetic STEMI patients; leaves open prospective validation before practice change.
Cohort (n=1,300)
Does the acute-to-chronic glycemic ratio (ABG/eAG) improve prognostic prediction compared to admission blood glucose alone for in-hospital outcomes in patients with STEMI undergoing PCI?
Odds Ratio: 2.45 (95% CI 1.24–4.82)
p-value: p=.010
The acute-to-chronic glycemic ratio is a better predictor of adverse in-hospital outcomes than admission blood glucose alone in diabetic patients presenting with STEMI and undergoing PCI.
Gao et al. (2019) conducted a cohort in ST-segment elevation myocardial infarction (STEMI) (n=1,300). Acute-to-chronic glycemic ratio (ABG/eAG) vs. Admission blood glucose (ABG) was evaluated on Composite of in-hospital all-cause death, cardiogenic shock, and acute pulmonary edema (OR 2.45, 95% CI 1.24-4.82, p=.010). The acute-to-chronic glycemic ratio (ABG/eAG) was associated with adverse in-hospital outcomes in diabetic patients with STEMI undergoing PCI (OR 2.45; 95% CI 1.24-4.82; P=0.010).